lysine has been researched along with Diabetic Glomerulosclerosis in 102 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (4.90) | 18.7374 |
1990's | 19 (18.63) | 18.2507 |
2000's | 40 (39.22) | 29.6817 |
2010's | 29 (28.43) | 24.3611 |
2020's | 9 (8.82) | 2.80 |
Authors | Studies |
---|---|
Fan, H; Fan, Y; Huang, L; Li, P; Liu, Q; Zhou, Y | 1 |
Balakrishna, S; Dias, CG; Venkataswamy, L | 1 |
Ardjmand, A; Ghavipanjeh, G; Jozi, F; Kheiripour, N; Nasehi, Z; Shahaboddin, ME; Taheri, MA | 1 |
Chavan, A; Dwivedi, S; Paul, AT | 1 |
Choi, CW; Chung, YH; Ha, SK; Han, EH; Huh, YH; Hyon, JY; Jeong Ha, S; Jeong, HG; Jung, SK; Kim, HJ; Kim, Y; Lee, H; Lee, J; Min, JY; Park, J; Yun, SH | 1 |
Kastberger, B; Schwarzbauer, JE; Vega, ME; Wehrle-Haller, B | 1 |
Correa-Giannella, MLC; Lira, ALA; Minanni, CA; Nakandakare, ER; Passarelli, M; Pinto, RS; Queiroz, MS; Ronsein, GE; Santana, MFM; Sawada, MIBAC; Silva, ARM | 1 |
Cui, Z; Feng, H; Gu, X; Li, C; Liu, Y; Lu, Y; Lv, T; Sheng, W; Wan, Q; Yang, Z; Zhu, S | 1 |
Barozzino, M; Casagrande, V; Castellano, G; Cinefra, C; Conserva, F; Divella, C; Federici, M; Gallone, A; Gesualdo, L; Giorgino, F; Menghini, R; Pesce, F; Pontrelli, P; Rossini, M; Simone, S; Stallone, G; Stasi, A | 1 |
An, X; He, M; Li, L; Wang, B; Yao, Q; Zhang, J; Zhang, L | 1 |
Gao, C; Li, N; Liang, K; Liu, M; Peng, J; Su, H; Sun, Y; Wang, X; Wang, Z; Wei, X; Yi, F; Zhang, C; Zhang, Y; Zhen, J; Zhou, M; Zhou, Z | 1 |
Barozzino, M; Castellano, G; Conserva, F; Divella, C; Fiore, MG; Gallone, A; Gesualdo, L; Giorgino, F; Laviola, L; Oranger, A; Papale, M; Piscitelli, D; Pontrelli, P; Rossi, R; Simone, S | 1 |
Ahmad, B; Chiew, Y; Kadir, KA; Tan, SMQ | 1 |
Nakaya, I; Nakayama, K; Nakayama, M; Soma, J; Tezuka, Y; Yahata, M | 1 |
Abdollahi, M; Das, S; Jia, Y; Lanting, L; Natarajan, R; Oh, HJ; Reddy, MA; Wang, M; Yuan, H; Zhang, E | 1 |
Aa, J; Cao, B; Ge, Y; Li, M; Liu, L; Liu, Z; Qin, W; Shi, J; Wang, G; Wang, X; Yu, X; Zha, W; Zhao, C; Zheng, T | 1 |
Dahl-Jørgensen, K; Fagerland, MW; Hanssen, KF; Jørum, E; Karimé, B; Mellgren, SI; Monnier, VM; Sveen, KA | 1 |
Amann, K; Bondeva, T; Daniel, C; Franke, S; Liebisch, M; Wolf, G | 1 |
Hedayati, M; Hosseinpanah, F; Nafar, M; Noori, N; Tabibi, H | 1 |
Cui, WP; Guo, QY; Miao, LN; Sun, GD | 1 |
Cui, W; Kong, L; Li, X; Luo, M; Miao, L; Tan, Y; Wu, H; Xu, F; Zhou, S | 1 |
Poretsky, L; Striker, GE; Vlassara, H; Woodward, M; Yubero-Serrano, EM | 1 |
Jing, Z; Kuang, L; Liu, N; Yang, J | 1 |
Borsos, AM; M'bemba, J; Peyroux, J; Selam, JL; Slama, G; Sternberg, M; Urios, P | 1 |
Sun, H; Sun, Z; Yuan, Y | 1 |
Beisswenger, PJ; Howell, S; Knowler, WC; Lemley, KV; Mauer, M; Nelson, RG; Saulnier, PJ; Tanamas, SK; Weil, EJ; Wheelock, KM; Yee, B | 1 |
Cui, P; Guo, Q; Han, H; Li, C; Li, Q; Li, X; Liu, S; Sun, G | 1 |
Gaikwad, AB; Goru, SK; Kadakol, A; Malek, V; Pandey, A; Sharma, N | 1 |
Aoki, T; Funabiki, K; Gohda, T; Gotoh, H; Matsumoto, M; Moon, JY; Ohsawa, I; Shibata, T; Tanimoto, M; Tomino, Y | 1 |
Grossin, N; Guillausseau, PJ; Massin, P; Meas, T; Wautier, JL; Wautier, MP | 1 |
Chang, CJ; Liou, SS; Liu, IM; Tzeng, TF | 1 |
An, XF; Gao, F; Gu, WJ; Huang, S; Liu, JS; Ten, SC; Wang, X; Yu, JY; Zhao, Y | 1 |
Erhard, P; Genuth, S; Kern, EF; Sun, W; Weiss, MF | 1 |
Burrell, LM; Cooper, ME; Coughlan, MT; Forbes, JM; Jerums, G; MacIsaac, RJ; Patel, SK; Penfold, SA; Sourris, KC; Srivastava, PM; Steer, D; Thomas, MC; Webster, DE | 1 |
Kang, KS; Kim, HY; Park, JH; Yamabe, N; Yokozawa, T | 1 |
Aiello, LP; Asztalos, BF; Cavallerano, JD; Doria, A; Keenan, HA; King, GL; Monnier, VM; Schaefer, EJ; Sell, DR; Strauch, CM; Sun, JK | 1 |
Coughlan, MT; Forbes, JM | 1 |
Ishii, M; Miyazaki, A; Sanaka, T | 1 |
Lin, CY; Yin, MC | 1 |
Ben Yahia, S; Bouzidi, H; Hammami, M; Kerkeni, M; Letaief, A; Saïdi, A | 1 |
Berger, S; Blackburn, MR; Borok, Z; Chen, L; Jin, J; Li, JM; Liu, M; Wang, Y; Wu, H; Xia, Y; Xiao, Z; Yin, H; Zhang, W; Zhang, X; Zhou, B; Zhou, Q | 1 |
Brammar, G; Burns, WC; Cao, Z; Cooper, ME; Forbes, JM; MCLennan, SV; Twigg, SM | 1 |
Abd el Baki, RF; Andrassy, M; Bierhaus, A; Dugi, KA; Haering, HU; Hamann, A; Kasper, M; Kloeting, I; Mentz, S; Merz, W; Morcos, M; Nawroth, PP; Sayed, AA; Schleicher, E; Schmidt, AM; Schwenger, V; Stern, D; Tritschler, H; van der Woude, F; Waldherr, R; Yard, B; Ziegler, R | 1 |
Koo, JR; Vaziri, ND | 1 |
Aoyama, I; Enomoto, A; Nakamura, S; Niwa, T; Tachikawa, T; Takayama, F; Tobita, K | 1 |
Blazícek, P; Dzúrik, R; Gazdíková, K; Heidland, A; Schinzel, R; Sebeková, K; Spustová, V; Syrová, D | 1 |
Bárány, P; Heimburger, O; Hoff, CM; Holmes, CJ; Lindholm, B; Marchlewska, A; Nordfors, L; Pecoits-Filho, R; Schalling, M; Stenvinkel, P; Suliman, M | 1 |
Inagi, R; Ishikawa, N; Koike, H; Kurokawa, K; Miyata, T; Mizuno, M; Nangaku, M; Sada, T; Ueda, Y; van Ypersele de Strihou, C; Yuzawa, H | 1 |
Burns, WC; Cooper, ME; Forbes, JM; Founds, HW; Jerums, G; Thallas, V; Thomas, MC | 1 |
Abe, M; Hisano, S; Horiuchi, S; Iwasaki, H; Nangaku, M; Sakata, N; Uesugi, N | 1 |
Aso, Y; Inukai, T; Sekine, K; Takanashi, K; Takebayashi, K; Yoshida, N; Yoshihara, K | 1 |
Hirata, K; Kubo, K | 1 |
Bassal, S; Cooper, ME; Deemer, ER; El-Osta, A; Forbes, JM; Jerums, G; Long, DM; Osicka, TM; Panagiotopoulos, S; Pete, J; Thallas-Bonke, V; Thomas, MC; Thorpe, SR | 1 |
Hosokawa, T; Sanaka, T | 1 |
Baynes, JW; Bleich, M; Busch, AE; Deemer, EK; Dingermann, T; Huber, J; Münch, G; Schäfer, S; Schmid, K; Somoza, V; Wihler, C | 1 |
Inagi, R; Izuhara, Y; Kurokawa, K; Miyata, T; Nangaku, M; Shibata, T; Sugiyama, S; Usuda, N; van Ypersele de Strihou, C | 1 |
Cleary, P; Dahms, W; Genuth, S; Malone, J; Monnier, VM; Sell, DR; Sivitz, W; Sun, W | 1 |
Cottalasso, D; Furfaro, AL; Marinari, UM; Menini, S; Odetti, P; Patriarca, S; Pesce, C; Pronzato, MA; Traverso, N | 1 |
Słowik-Zyłka, D | 1 |
Basgen, J; Brem, H; Cai, W; Li, Z; Peppa, M; Uribarri, J; Vlassara, H; Zhang, JG | 1 |
Brandstädt, A; Busch, M; Franke, S; Gerth, J; Hunsicker, LG; Ott, U; Stein, G; Wolf, G | 1 |
Aoki, T; Gohda, T; Hagiwara, S; Horikoshi, S; Ito, T; Kaneko, S; Matsumoto, M; Murakoshi, M; Tanimoto, M; Tomino, Y; Yamada, K | 1 |
Busch, M; Franke, S; Stein, G; Wolf, G | 1 |
Bach, LA; Cooper, ME; Coughlan, MT; Forbes, JM; Fukami, K; Penfold, SA; Sourris, KC; Thallas-Bonke, V; Thorpe, SR; Yap, FY | 1 |
Izuhara, Y; Miyata, T; Nangaku, M; Ohtomo, S; Strihou, Cv; Takizawa, S | 1 |
Calabrese, V; Calafato, S; Castellino, P; Cornelius, C; Di Mauro, M; Finocchiaro, M; Mancuso, C; Mangiameli, A; Puleo, E; Sapienza, M; Stella, AM | 1 |
Kang, KS; Kim, HY; Yamabe, N; Yokozawa, T | 1 |
Busch, M; Franke, S; Rohde, RD; Stein, G; Wolf, G | 1 |
Monnier, VM; Sell, DR; Shen, W; Strauch, CM | 1 |
Mogensen, CE; Sølling, K; Vittinghus, E | 1 |
Denda, M; Inoue, T; Ishihara, C; Kushida, K; Takahashi, M | 1 |
Friedlander, MA; Hricik, DE; Monnier, VM; Schulak, JA; Wu, YC | 1 |
Beisswenger, PJ; Brinck-Johnsen, T; Curphey, TJ; Moore, LL | 1 |
Fogarty, JF; Hricik, DE; Monnier, VM; Schulak, JA; Sell, DR | 1 |
Bailie, KE; Baynes, JW; Dunn, JA; Dyer, DG; Lyons, TJ; McCance, DR; Thorpe, SR | 1 |
Iida, Y; Kurokawa, K; Maeda, K; Miyata, T; Shinzato, T; Tanaka, S; Ueda, Y; van Ypersele de Strihou, C | 1 |
Brandt, R; Hanschke, R; Hartmann, K; Hehmke, B; Jäger, B; Kasbohm, J; Krantz, S; Landmesser, C; Michaelis, D; Vogt, L | 1 |
Horie, K; Iida, Y; Maeda, K; Miyata, T; Sugiyama, S; Tanaka, H; Tsuyuki, M | 1 |
Blanco, MC; Camejo, M; Contreras, I; Giansante, E; Gonzalez, F; Lopez, T; Martinez, N; Molina, M; Postalian, S; Reiser, KM; Sanchez, MR; Suarez, N | 1 |
Izumi, G; Kobayashi, N; Kumano, K; Sakai, T; Shibata, K; Wang, H; Yokota, S; Yoshida, A; Yoshihara, T | 1 |
Horie, K; Kurokawa, K; Maeda, K; Miyata, S; Miyata, T; Monnier, VM; Sakai, H; Sugiyama, S; van Ypersole de Strihou, C; Witztum, JL | 1 |
Hricik, DE; Justice, AC; Rodby, RA; Weiss, MF | 1 |
Kawashima, S; Kurokawa, K; Maeda, K; Miyata, T; Sugiyama, S; Tanaka, H; Ueda, Y; Van Ypersele de Strihou, C | 1 |
Horiuchi, S; Imanaga, Y; Meng, J; Nagai, R; Sakata, N; Tachikawa, Y; Takebayashi, S | 1 |
Horie, K; Inagi, R; Izuhara, Y; Kurokawa, K; Miyata, T; Sakai, H; Saotome, N; Suzuki, D; Uchida, K; Yagame, M; Yasuda, Y | 1 |
Aoyama, I; Katsuzaki, T; Miyazaki, T; Niwa, T; Shimokata, K; Takayama, F; Tsukushi, S | 1 |
Daimon, M; Eguchi, H; Hirata, A; Igarashi, M; Kato, T; Manaka, H; Ohnuma, H; Ono, Y; Saito, T; Yamaguchi, H | 1 |
Inagi, R; Kurokawa, K; Miyata, T; Sugiyama, S; Suzuki, D | 1 |
Böhmer, KP; Haas, A; Hartner, A; Hilgers, KF; Sterzel, RB; Veelken, R | 1 |
D'Agati, VD; Fu, C; Kislinger, T; Markowitz, GS; Pischetsrieder, M; Schmidt, AM; Stern, D; Taguchi, A; Tanji, N | 1 |
Aricó, CN; Bernich, P; Fedele, D; Gammaro, L; Lapolla, A; Tessitore, N | 1 |
Jyothirmayi, GN; Modak, R; Reddi, AS | 1 |
Horiuchi, S; Imanaga, Y; Meng, J; Nagai, R; Sakata, N; Takebayashi, S | 1 |
Bakala, H; Depreux, P; Fourmaintraux, E; Schwedler, SB; Striker, GE; Striker, LJ; Verbeke, P; Vilar, J; Weiss, MF | 1 |
Heidland, A; Kientsch-Engel, R; Mazák, I; Nagy, J; Schinzel, R; Wagner, Z; Wittmann, I | 1 |
Horiuchi, S; Meng, J; Nagai, R; Saito, T; Sakata, N; Takebayashi, S; Takeya, M; Uesugi, N | 1 |
Antolini, F; Buoncristiani, U; Fagugli, RM; Floridi, A; Floridi, E; Galli, F | 1 |
Mogensen, CE | 1 |
Munakata, H; Sato, T; Yoshinaga, K; Yosizawa, Z | 1 |
Fogarty, J; Lapolla, A; Monnier, VM; Odetti, P; Sell, DR | 1 |
Bassiouny, AR; McDonald, TL; Rosenberg, H; Thiele, GM | 1 |
Oguma, S; Sato, T; Yoshinaga, K | 1 |
6 review(s) available for lysine and Diabetic Glomerulosclerosis
Article | Year |
---|---|
SET7, a lysine-specific methyl transferase: An intriguing epigenetic target to combat diabetic nephropathy.
Topics: Animals; Diabetes Mellitus; Diabetic Nephropathies; Epigenesis, Genetic; Histone-Lysine N-Methyltransferase; Lysine; Transferases | 2023 |
Histone lysine methylation in diabetic nephropathy.
Topics: Animals; Blood Glucose; Chromatin Assembly and Disassembly; Diabetic Nephropathies; Gene Expression Regulation; Histone Demethylases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methylation; Signal Transduction | 2014 |
The role of microRNAs in diabetic nephropathy.
Topics: Acetylation; Animals; Chromatin; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; Dogs; Epigenesis, Genetic; Epigenomics; Histones; Humans; Inflammation; Kidney; Lysine; Methylation; Mice; Mice, Transgenic; MicroRNAs; Rats | 2014 |
[Measurement of plasma pentosidine and the clinical significance in diagnosis of diabetic nephropathies].
Topics: Arginine; Biomarkers; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Female; Glycation End Products, Advanced; Humans; Kidney Failure, Chronic; Lysine; Male; Oxidative Stress; Reagent Kits, Diagnostic; ROC Curve; Sensitivity and Specificity | 2005 |
Advanced glycation end-products in diabetic nephropathy.
Topics: Animals; Arginine; Blood Glucose; Diabetic Nephropathies; Glycation End Products, Advanced; Glycosylation; Humans; Immunohistochemistry; Lysine; Norleucine; Proteins; Pyrroles | 1996 |
Hemodialysis techniques and advanced glycation end products.
Topics: Arginine; Blood Proteins; Chromatography, High Pressure Liquid; Diabetic Nephropathies; Glycation End Products, Advanced; Hemodiafiltration; Hemodialysis Solutions; Hemofiltration; Humans; Kidney Failure, Chronic; Lysine; Membranes, Artificial; Molecular Weight; Renal Dialysis; Ultrafiltration; Uremia | 2001 |
10 trial(s) available for lysine and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial.
Topics: Aged; Albuminuria; Biomarkers; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Kidney; Lysine; Malaysia; Male; Middle Aged; Pilot Projects; Prospective Studies; Time Factors; Tocotrienols; Treatment Outcome | 2018 |
Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation end-products, and blood pressure in diabetic nephropathy.
Topics: Adult; Aged; Albuminuria; Arginine; Blood Pressure; Creatinine; Diabetic Nephropathies; Double-Blind Method; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Pyridoxine; Thioctic Acid | 2013 |
Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.
Topics: Adiponectin; Age Factors; Aged; Albuminuria; Chelating Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Estrogen Receptor alpha; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Intention to Treat Analysis; Lysine; Male; Metformin; Middle Aged; NF-E2-Related Factor 2; Pyruvaldehyde; Receptor for Advanced Glycation End Products; Receptors, Tumor Necrosis Factor, Type I; RNA, Messenger; Sevelamer; Sex Factors; Single-Blind Method; Sirtuin 1; White People | 2015 |
Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes.
Topics: Adult; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Imidazoles; Indians, North American; Kidney; Kidney Glomerulus; Losartan; Lysine; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Pyruvaldehyde | 2016 |
[Reduction of carbonyl stress with renal replacement therapy in chronic renal failure].
Topics: Adult; Arginine; Body Mass Index; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lysine; Oxidative Stress; Renal Dialysis; Treatment Outcome; Ultrafiltration | 2004 |
Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arginine; Biphenyl Compounds; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Hypertension; Irbesartan; Linear Models; Lysine; Male; Middle Aged; Statistics, Nonparametric; Tetrazoles | 2008 |
Effects of aspirin or basic amino acids on collagen cross-links and complications in NIDDM.
Topics: Analysis of Variance; Arginine; Aspirin; Biopsy; Blood Glucose; Collagen; Cross-Linking Reagents; Cyclooxygenase Inhibitors; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Double-Blind Method; Glycated Hemoglobin; Lysine; Placebos; Skin | 1997 |
Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Collaborative Study Group.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Arginine; Biomarkers; Captopril; Creatinine; Cross-Linking Reagents; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Lysine; Male; Neopterin; Predictive Value of Tests; Survival Analysis | 1998 |
Plasma levels of pentosidine in diabetic patients: an advanced glycation end product.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Analysis of Variance; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Male; Middle Aged; Myocardial Ischemia; Regression Analysis; Sensitivity and Specificity; Severity of Illness Index | 1998 |
Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions.
Topics: Adult; Biomarkers; Biopsy, Needle; Culture Techniques; Diabetic Nephropathies; Female; Glomerular Mesangium; Glomerulonephritis, IGA; Glycation End Products, Advanced; Humans; Immunohistochemistry; Kidney Function Tests; Lysine; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Protein Denaturation; Reference Values; Sensitivity and Specificity | 1999 |
86 other study(ies) available for lysine and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Mitogen-activating protein kinase kinase kinase kinase-3, inhibited by Astragaloside IV through H3 lysine 4 monomethylation, promotes the progression of diabetic nephropathy by inducing apoptosis.
Topics: Animals; Apoptosis; Creatinine; Diabetes Mellitus; Diabetic Nephropathies; Female; Lysine; Male; Mice; Mitogens; Protein Kinases; Protein Serine-Threonine Kinases; Rats, Sprague-Dawley; Saponins; Triterpenes | 2022 |
Diabetic nephropathy patients show hyper-responsiveness to N6-carboxymethyllysine.
Topics: Culture Media, Conditioned; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Lysine; NF-kappa B | 2022 |
L-Lysine Ameliorates Diabetic Nephropathy in Rats with Streptozotocin-Induced Diabetes Mellitus.
Topics: Animals; Antioxidants; Blood Glucose; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glycation End Products, Advanced; Insulin; Kidney; Lipids; Lysine; Male; Oxidative Stress; Rats; Rats, Wistar; Streptozocin; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2022 |
Mitochondrial carnitine palmitoyltransferase 2 is involved in N
Topics: Animals; Blood Glucose; Carnitine O-Palmitoyltransferase; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Glycated Hemoglobin; Humans; Kidney; Lysine; Male; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Mitochondria | 2020 |
Stimulation of Fibronectin Matrix Assembly by Lysine Acetylation.
Topics: Acetylation; Animals; Diabetic Nephropathies; Extracellular Matrix; Fibronectins; Humans; Lysine; Mice | 2020 |
Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis.
Topics: Aged; Aged, 80 and over; Albuminuria; Apolipoproteins A; Apolipoproteins D; Arginine; Case-Control Studies; Diabetic Nephropathies; Female; Gene Expression; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Interleukin-6; Kidney; Lipopolysaccharides; Lipoproteins, HDL; Lysine; Macrophages; Male; Middle Aged; Primary Cell Culture; Protein Carbamylation; Proteome; Renal Dialysis; Risk Factors; Tumor Necrosis Factor-alpha | 2020 |
General Control of Amino Acid Synthesis 5-Like 1-Mediated Acetylation of Manganese Superoxide Dismutase Regulates Oxidative Stress in Diabetic Kidney Disease.
Topics: Acetylation; Animals; Cell Line; Diabetic Nephropathies; Disease Models, Animal; Down-Regulation; Epithelial Cells; Epithelial-Mesenchymal Transition; Glucose; Humans; Inflammation; Kidney Tubules; Lysine; Male; Mice, Inbred C57BL; Mitochondrial Proteins; Nerve Tissue Proteins; Oxidative Stress; Proteinuria; Reactive Oxygen Species; Streptozocin; Superoxide Dismutase; Ubiquitination | 2021 |
Inhibition of Lysine 63 Ubiquitination Prevents the Progression of Renal Fibrosis in Diabetic DBA/2J Mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Female; Fibrosis; Lysine; Mice; Mice, Inbred DBA; Nitrofurans; Ramipril; Sulfones; Ubiquitination | 2021 |
The receptor for advanced glycation endproducts mediates podocyte heparanase expression through NF-κB signaling pathway.
Topics: Animals; Base Sequence; Cattle; Diabetic Nephropathies; Glucuronidase; Glycation End Products, Advanced; HMGB1 Protein; Kidney Cortex; Lysine; Mice, Inbred C57BL; NF-kappa B; Phosphorylation; Podocytes; Promoter Regions, Genetic; Protein Binding; Proteinuria; Receptor for Advanced Glycation End Products; S100 Proteins; Serum Albumin, Bovine; Signal Transduction; Transcription Factor RelA; Up-Regulation | 2018 |
Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.
Topics: Acetylation; Animals; Apoptosis; Autophagy; Biopsy; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Down-Regulation; Doxorubicin; Gene Deletion; Histones; Humans; Inflammation; Integrases; Kidney; Lysine; Male; Mice, Knockout; Podocytes; Promoter Regions, Genetic; Proteinuria; Rats; Receptors, Notch; Signal Transduction; Sirtuins | 2017 |
Deregulation of autophagy under hyperglycemic conditions is dependent on increased lysine 63 ubiquitination: a candidate mechanism in the progression of diabetic nephropathy.
Topics: Adult; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Diabetic Nephropathies; Disease Progression; Epithelial Cells; Female; Fluorescent Antibody Technique; Gene Expression; Gene Silencing; Humans; Hyperglycemia; Immunohistochemistry; Kidney Tubules; Lysine; Male; Microtubule-Associated Proteins; Middle Aged; Ubiquitination | 2018 |
Methylglyoxal as a prognostic factor in patients with chronic kidney disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Deoxyglucose; Diabetic Nephropathies; Disease Progression; Female; Humans; Japan; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyruvaldehyde; Renal Insufficiency, Chronic; Risk Factors; Time Factors; Up-Regulation | 2019 |
Dysregulation of histone H3 lysine 27 trimethylation in transforming growth factor-β1-induced gene expression in mesangial cells and diabetic kidney.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Expression Regulation; Histones; Humans; Injections, Intraperitoneal; Lysine; Male; Mesangial Cells; Methylation; Mice; Mice, Inbred C57BL; Rats; Rats, Sprague-Dawley; Streptozocin; Transforming Growth Factor beta1 | 2019 |
GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy.
Topics: 3-Hydroxybutyric Acid; Albuminuria; Allantoin; Amino Acids; Animals; Arachidonic Acid; Biomarkers; Cholesterol; Citric Acid; Citric Acid Cycle; Diabetic Nephropathies; Gas Chromatography-Mass Spectrometry; Glycolysis; Hydrogen-Ion Concentration; Lipid Metabolism; Lysine; Malates; Male; Metabolomics; Mice; Mice, Inbred C57BL; Succinic Acid; Urine | 2013 |
Small- and large-fiber neuropathy after 40 years of type 1 diabetes: associations with glycemic control and advanced protein glycation: the Oslo Study.
Topics: Adolescent; Adult; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Imidazoles; Lysine; Male; Middle Aged; Nerve Fibers; Pyruvaldehyde; Sensory Thresholds; Young Adult | 2013 |
Activation of the receptor for advanced glycation end products induces nuclear inhibitor of protein phosphatase-1 suppression.
Topics: Animals; Apoptosis; Case-Control Studies; Cell Cycle Checkpoints; Cell Enlargement; Cell Proliferation; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p27; Diabetic Nephropathies; Down-Regulation; Endoribonucleases; Glycation End Products, Advanced; Humans; Intracellular Signaling Peptides and Proteins; Lysine; Mice; Necrosis; NF-kappa B; Phosphoprotein Phosphatases; Podocytes; Receptor for Advanced Glycation End Products; RNA-Binding Proteins; RNA, Messenger; RNA, Small Interfering; Serum Albumin, Bovine | 2014 |
LC-MS/MS for the simultaneous determination of polar endogenous ADMA and CML in plasma and urine from diabetics.
Topics: Arginine; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Linear Models; Lysine; Retrospective Studies; Tandem Mass Spectrometry | 2015 |
Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
Topics: Adult; Albuminuria; Arginine; Biomarkers; Biopsy; Case-Control Studies; Collagen; Creatinine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Disease Progression; Female; Fluorescence; Humans; Longitudinal Studies; Lysine; Male; Middle Aged; Skin; Spectrometry, Fluorescence | 2016 |
Update on Mechanisms of Renal Tubule Injury Caused by Advanced Glycation End Products.
Topics: ATP Binding Cassette Transporter 1; Cell Line; Cholesterol; Diabetic Nephropathies; Endoplasmic Reticulum Stress; Epithelial Cells; Foam Cells; Glycation End Products, Advanced; Humans; Kidney Tubules; Lipid Metabolism; Liver X Receptors; Lysine; Receptors, LDL; Sterol Regulatory Element Binding Protein 2 | 2016 |
Involvement of Histone Lysine Methylation in p21 Gene Expression in Rat Kidney In Vivo and Rat Mesangial Cells In Vitro under Diabetic Conditions.
Topics: Animals; Antibodies; Blotting, Western; Cyclin-Dependent Kinase Inhibitor p21; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Expression Regulation; Glucose; Histone Code; Histone-Lysine N-Methyltransferase; In Vitro Techniques; Kidney Glomerulus; Lysine; Male; Mesangial Cells; Methylation; Promoter Regions, Genetic; Rats; Rats, Wistar; Transforming Growth Factor beta1 | 2016 |
H2AK119 monoubiquitination regulates Angiotensin II receptor mediated macrophage infiltration and renal fibrosis in type 2 diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blotting, Western; Chemokine CCL2; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fibrosis; Histones; Imidazoles; Kidney; Lysine; Macrophages; Male; Promoter Regions, Genetic; Pyridines; Rats, Wistar; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; Telmisartan; Transforming Growth Factor beta1; Ubiquitination | 2016 |
Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function.
Topics: Aged; Arginine; Carotid Arteries; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Lysine; Male; Middle Aged; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Renal Dialysis; Severity of Illness Index; Tunica Intima; Tunica Media; Ultrasonography | 2008 |
Severity of diabetic microvascular complications is associated with a low soluble RAGE level.
Topics: Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lysine; Male; Middle Aged; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2008 |
The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription.
Topics: Albuminuria; Animals; Blood Glucose; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drugs, Chinese Herbal; Fibronectins; Glycation End Products, Advanced; Hypoglycemic Agents; Kidney; Lysine; Magnoliopsida; Male; Mitochondria; NF-kappa B; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Thiobarbituric Acid Reactive Substances; Transforming Growth Factor beta1 | 2009 |
Plasma sRAGE is not associated with urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage.
Topics: Age of Onset; Aged; Albuminuria; Blood Glucose; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Lipids; Lysine; Male; Middle Aged; Patient Selection; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2010 |
Early urinary markers of diabetic kidney disease: a nested case-control study from the Diabetes Control and Complications Trial (DCCT).
Topics: Acetylglucosaminidase; Adolescent; Adult; Albuminuria; Arginine; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Predictive Value of Tests; Young Adult | 2010 |
Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy.
Topics: Aged; Antibodies, Neutralizing; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Female; HMGB1 Protein; Humans; Ligands; Lysine; Male; Middle Aged; Molecular Weight; Protein Kinase C-alpha; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Transcription, Genetic | 2010 |
Effects of heat-processed ginseng and its active component ginsenoside 20(S)-Rg3 on the progression of renal damage and dysfunction in type 2 diabetic Otsuka Long-Evans Tokushima Fatty rats.
Topics: Animals; Antioxidants; Blood Glucose; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Ginsenosides; Glycation End Products, Advanced; Hypoglycemic Agents; Kidney; Kidney Diseases; Lipid Peroxidation; Lipids; Lysine; Male; Nitric Oxide Synthase Type II; Oxidative Stress; Panax; Phytotherapy; Plant Extracts; Proteinuria; Rats; Rats, Inbred OLETF; Thiobarbituric Acid Reactive Substances | 2010 |
Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study.
Topics: Aged; Arginine; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Male; Middle Aged | 2011 |
Temporal increases in urinary carboxymethyllysine correlate with albuminuria development in diabetes.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Albuminuria; Animals; Biomarkers; Cytosol; Deoxyguanosine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Expression; Glomerular Filtration Rate; Glycation End Products, Advanced; Kidney Cortex; Lysine; Male; Mitochondria; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; RNA, Messenger; Streptozocin; Time Factors | 2011 |
[Pentosidine].
Topics: Arginine; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Humans; Lysine | 2010 |
Renal protective effects of extracts from guava fruit (Psidium guajava L.) in diabetic mice.
Topics: Aldehyde Reductase; Animals; Anti-Inflammatory Agents; Antioxidants; Arginine; Blood Glucose; Blood Urea Nitrogen; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Fructose; Fruit; Hypoglycemic Agents; Insulin; Kidney; Lysine; Male; Mice; Mice, Inbred BALB C; Phytotherapy; Plant Extracts; Psidium; Reactive Oxygen Species | 2012 |
Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients.
Topics: Aged; Arginine; Biomarkers; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glycation End Products, Advanced; Humans; Hyperlipidemias; Hypertension; Lysine; Male; Microvessels; Middle Aged; Prospective Studies; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Severity of Illness Index; Up-Regulation | 2013 |
Aqp5 is a new transcriptional target of Dot1a and a regulator of Aqp2.
Topics: Amino Acid Sequence; Animals; Aquaporin 2; Aquaporin 5; Base Sequence; Cell Nucleus; Chromatin Immunoprecipitation; Diabetic Nephropathies; Endoplasmic Reticulum; Golgi Apparatus; Histone-Lysine N-Methyltransferase; Histones; Humans; Kidney; Lysine; Methylation; Methyltransferases; Mice; Molecular Sequence Data; Oligonucleotide Array Sequence Analysis; Polyuria; Protein Binding; Protein Transport; Regulatory Sequences, Nucleic Acid; RNA, Messenger; Transcription, Genetic; Up-Regulation | 2013 |
Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine.
Topics: Animals; Cells, Cultured; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibronectins; Gene Expression; Glomerular Mesangium; Glycation End Products, Advanced; Guanidines; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Lysine; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Serum Albumin, Bovine | 2002 |
Activation of tubular epithelial cells in diabetic nephropathy.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Epithelium; Glycation End Products, Advanced; Humans; Kidney; Kidney Tubules; Lysine; NF-kappa B; Rats; Rats, Brattleboro; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reference Values; Serum Albumin; Transcription, Genetic; Urine | 2002 |
Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species.
Topics: Animals; Antioxidants; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Insulin; Lysine; Male; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Tyrosine | 2003 |
An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
Topics: Age Factors; Animals; Antibodies, Monoclonal; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Fluorescent Antibody Technique, Indirect; Glomerular Mesangium; Glycation End Products, Advanced; Kidney; Kidney Glomerulus; Lysine; Rats; Rats, Inbred OLETF; Rats, Inbred Strains; Thiadiazoles; Thiazolidines | 2003 |
Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Glucose; Blood Pressure; Creatinine; Cystatin C; Cystatins; Diabetic Nephropathies; Female; Glomerulonephritis; Glycation End Products, Advanced; Homocysteine; Humans; Lipofuscin; Lysine; Male; Malondialdehyde; Middle Aged; Nephritis, Interstitial; Oxidative Stress; Polycystic Kidney Diseases; Ramipril; Severity of Illness Index; Statistics as Topic; Treatment Outcome | 2003 |
A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients.
Topics: Arginine; Arteriosclerosis; Chlamydia Infections; Chlamydophila pneumoniae; Diabetic Nephropathies; Female; Genotype; Humans; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Oxidative Stress; Peroxidase; Polymorphism, Single Nucleotide; Risk Factors | 2003 |
Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model.
Topics: Animals; Antihypertensive Agents; Arginine; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glycation End Products, Advanced; Hydralazine; Hypertension, Renal; Imidazoles; Immunohistochemistry; In Vitro Techniques; Kidney; Lipids; Lysine; Male; Olmesartan Medoxomil; Oxidation-Reduction; Proteinuria; Rats; Tetrazoles | 2003 |
The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.
Topics: Albuminuria; Animal Population Groups; Animals; Blood Pressure; Collagen; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Glycation End Products, Advanced; Immediate-Early Proteins; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Kidney; Kinetics; Lysine; Models, Biological; Rats; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Solubility; Thiazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tyrosine | 2003 |
Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: glycoxidation-mediated local complement activation.
Topics: Acrolein; Adult; Aged; Aged, 80 and over; Arteriosclerosis; Complement Activation; Complement Membrane Attack Complex; Diabetic Nephropathies; Female; Glomerulosclerosis, Focal Segmental; Glycation End Products, Advanced; Humans; Hypertension; Kidney; Kidney Glomerulus; Lysine; Male; Middle Aged; Models, Biological; Nephrosclerosis; Oxidation-Reduction; Tunica Media | 2004 |
Dissociation between urinary pyrraline and pentosidine concentrations in diabetic patients with advanced nephropathy.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Arginine; beta 2-Microglobulin; Biomarkers; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glycated Hemoglobin; Humans; Lysine; Pyrroles; Reference Values; Regression Analysis | 2004 |
Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
Topics: Arginine; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged | 2004 |
Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.
Topics: Alternative Splicing; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arginine; Blotting, Western; Cattle; Cells, Cultured; Collagen; Diabetic Nephropathies; DNA Primers; Endothelium, Vascular; Glycation End Products, Advanced; Humans; Immunohistochemistry; Immunoprecipitation; Kidney Cortex; Lysine; Male; Microscopy, Fluorescence; Molecular Weight; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; Skin; Time Factors; Up-Regulation | 2005 |
Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Ascorbic Acid; Blood Glucose; Chromatography, High Pressure Liquid; Creatine; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glycated Hemoglobin; Glycation End Products, Advanced; Heterocyclic Compounds, 3-Ring; Kidney; Lysine; Male; Oxidation-Reduction; Protease Inhibitors; Ramipril; Rats; Rats, Zucker; Spectrometry, Fluorescence | 2005 |
In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy.
Topics: Animals; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet, Fat-Restricted; Disease Models, Animal; Female; Follow-Up Studies; Glycation End Products, Advanced; Immunohistochemistry; Kidney; Lysine; Male; Microscopy, Electron; Obesity; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Wistar | 2005 |
Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications p
Topics: Adult; Biopsy; Collagen; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Disease Progression; Disease Susceptibility; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Prognosis; Skin; Time Factors | 2005 |
HNE-dependent molecular damage in diabetic nephropathy and its possible prevention by N-acetyl-cysteine and oxerutin.
Topics: Acetylcysteine; Aldehydes; Animals; Apoptosis; Cell Division; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glycation End Products, Advanced; Hydroxyethylrutoside; Immunohistochemistry; Kidney Glomerulus; Lipid Peroxidation; Lysine; Male; Rats; Rats, Wistar; Taurine | 2005 |
Prevention and reversal of diabetic nephropathy in db/db mice treated with alagebrium (ALT-711).
Topics: Animals; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Lysine; Mice; Mice, Mutant Strains; Thiazoles | 2006 |
The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Disease Progression; Female; Glycation End Products, Advanced; Humans; Hypertension; Lysine; Male; Middle Aged; Multivariate Analysis; Oxidative Stress; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Factors | 2006 |
Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice.
Topics: Animals; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Glycation End Products, Advanced; Immunohistochemistry; Laminin; Lysine; Male; Mice; Pyridoxamine; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Schiff Bases; Transforming Growth Factor beta1; Tyrosine | 2007 |
[Is the serum concentration of pentosidine a predictor of cardiovascular events in patients with type 2 diabetes and kidney disease?].
Topics: Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Lipoproteins, LDL; Lysine; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Prospective Studies; Risk Factors; Time Factors | 2007 |
Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
Topics: Acetophenones; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Glomerular Mesangium; Glycation End Products, Advanced; Lysine; Male; NADPH Oxidases; Protein Kinase C-alpha; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Superoxides | 2008 |
Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model.
Topics: Animals; Antimutagenic Agents; Arginine; Basic Helix-Loop-Helix Transcription Factors; Blood Pressure; Blotting, Western; Chromatography, High Pressure Liquid; Cobalt; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Gene Expression; Glycation End Products, Advanced; Hypertension; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immediate-Early Proteins; Insulin-Like Growth Factor Binding Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Lysine; Male; NADPH Oxidases; Obesity; Oxidative Stress; Polymerase Chain Reaction; Rats; Rats, Inbred SHR; RNA, Messenger; Transforming Growth Factor beta | 2008 |
Oxidative stress and cellular stress response in diabetic nephropathy.
Topics: Aldehydes; Arginine; Chaperonin 60; Diabetic Nephropathies; F2-Isoprostanes; Female; Heat-Shock Response; Heme Oxygenase-1; HSP70 Heat-Shock Proteins; Humans; Lymphocytes; Lysine; Male; Middle Aged; Oxidative Stress; Protein Carbonylation; Renal Insufficiency; Thioredoxin Reductase 1 | 2007 |
Role of maltol in advanced glycation end products and free radicals: in-vitro and in-vivo studies.
Topics: Animals; Blood Glucose; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Free Radicals; Glycated Serum Albumin; Glycation End Products, Advanced; Guanidines; Lysine; Male; Proteinuria; Pyrones; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Serum Albumin; Streptozocin; Transcription Factor RelA | 2008 |
Aging, diabetes, and renal failure catalyze the oxidation of lysyl residues to 2-aminoadipic acid in human skin collagen: evidence for metal-catalyzed oxidation mediated by alpha-dicarbonyls.
Topics: 2-Aminoadipic Acid; Adolescent; Adult; Aging; Child; Child, Preschool; Collagen; Diabetes Mellitus; Diabetic Nephropathies; Humans; Infant; Infant, Newborn; Lysine; Middle Aged; Oxidation-Reduction; Skin; Skin Aging | 2008 |
Studies on mechanisms of proteinuria using amino-acid-induced inhibition of tubular reabsorption in normal and diabetic man.
Topics: Albuminuria; Amino Acids; beta 2-Microglobulin; Diabetic Nephropathies; Humans; Kidney Tubules; Lysine; Male; Proteinuria | 1981 |
Plasma pentosidine levels in uremic patients before and after hemodialysis.
Topics: Arginine; beta 2-Microglobulin; Cross-Linking Reagents; Diabetic Nephropathies; Glycosylation; Humans; Kidney; Kidney Failure, Chronic; Lysine; Metabolic Clearance Rate; Renal Dialysis; Uremia | 1995 |
Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease.
Topics: Arginine; Chromatography, High Pressure Liquid; Cross-Linking Reagents; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Linear Models; Lysine; Male; Middle Aged; Peritoneal Dialysis; Peritoneum; Renal Dialysis; Skin | 1995 |
Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.
Topics: Adult; Age Factors; Arginine; Collagen; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Sex Factors; Time Factors | 1993 |
Effects of kidney or kidney-pancreas transplantation on plasma pentosidine.
Topics: Adult; Arginine; Diabetic Nephropathies; Female; Glycated Hemoglobin; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lysine; Male; Middle Aged; Models, Chemical; Pancreas Transplantation; Time Factors | 1993 |
Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Collagen; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Maillard Reaction; Male; Microcirculation; Middle Aged; Skin | 1993 |
Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine.
Topics: Animals; Arginine; beta 2-Microglobulin; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet; Glomerulonephritis; Humans; Kidney Failure, Chronic; Lysine; Maillard Reaction; Nephrectomy; Oxidation-Reduction; Protein Binding; Rats; Rats, Wistar; Serum Albumin; Uremia | 1996 |
Differential expression of fructosyllysine-specific receptors on monocytes and macrophages and possible pathophysiological significance.
Topics: Adult; Age of Onset; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Female; Fructosamine; Glycated Hemoglobin; Humans; Lysine; Macrophages; Male; Membrane Proteins; Middle Aged; Monocytes; Nuclear Proteins; Probability; Rats; Rats, Inbred BB; Reference Values; RNA-Binding Proteins | 1996 |
Kinetic analysis of furosine and pentosidine in CAPD patients.
Topics: Adult; Arginine; Chromatography, High Pressure Liquid; Diabetes Mellitus; Diabetic Nephropathies; Dialysis Solutions; Glycation End Products, Advanced; Humans; In Vitro Techniques; Kidney Failure, Chronic; Lysine; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Proteins; Renal Dialysis | 1997 |
Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
Topics: Adolescent; Adult; Aged; Animals; Antibodies; Arginine; Collagen; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Immunoenzyme Techniques; Kidney Glomerulus; Lipid Peroxidation; Lysine; Male; Malondialdehyde; Mice; Middle Aged; Nephrotic Syndrome; Norleucine; Pyrroles; Rabbits | 1997 |
Increased advanced glycation end products in atherosclerotic lesions of patients with end-stage renal disease.
Topics: Aged; Aorta; Apolipoproteins B; Arteriosclerosis; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Immunohistochemistry; Kidney Failure, Chronic; Lysine; Male; Middle Aged | 1999 |
Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: role of the polyol pathway.
Topics: Adult; Aged; Aldehyde Reductase; Arginine; Creatinine; Deoxyglucose; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Female; Glycation End Products, Advanced; Hemoglobins; Humans; Imidazoles; In Vitro Techniques; Lysine; Male; Middle Aged; Polymers; Renal Dialysis; Sorbitol; Uremia | 1999 |
Increased serum levels of pentosidine, but not carboxymethyl lysine, in type 2 diabetes without obvious diabetic nephropathy.
Topics: Albuminuria; Arginine; Biomarkers; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Middle Aged; Reference Values | 1999 |
Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy.
Topics: Animals; Carbohydrate Metabolism; Cells, Cultured; Diabetic Nephropathies; Glycation End Products, Advanced; Humans; Immunohistochemistry; Kidney Glomerulus; Lipid Metabolism; Lipid Peroxidation; Lysine; Malondialdehyde; Oxidation-Reduction; Rats | 1999 |
Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy.
Topics: Animals; Blood Pressure Determination; Blotting, Northern; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glomerular Filtration Rate; Hemodynamics; Isoenzymes; Kidney Function Tests; Kidney Glomerulus; Lysine; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Reference Values; Reverse Transcriptase Polymerase Chain Reaction; Streptozocin | 2000 |
Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.
Topics: Adult; Antibodies; Arginine; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Immunohistochemistry; Kidney Diseases; Lysine; Male; Middle Aged; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reference Values; RNA, Messenger | 2000 |
L-lysine reduces nonenzymatic glycation of glomerular basement membrane collagen and albuminuria in diabetic rats.
Topics: Albuminuria; Animals; Basement Membrane; Blood Glucose; Collagen; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glycated Hemoglobin; Glycosylation; Kidney Glomerulus; Lysine; Male; Rats; Rats, Wistar | 2001 |
Carboxymethyllysine in dermal tissues of diabetic and nondiabetic patients with chronic renal failure: relevance to glycoxidation damage.
Topics: Aged; Animals; Antibodies, Monoclonal; Collagen; Dermis; Diabetic Nephropathies; Endopeptidases; Enzyme-Linked Immunosorbent Assay; Female; Glycation End Products, Advanced; Humans; Kidney Failure, Chronic; Lysine; Male; Mice; Mice, Inbred BALB C; Middle Aged | 2001 |
N-phenacylthiazolium bromide decreases renal and increases urinary advanced glycation end products excretion without ameliorating diabetic nephropathy in C57BL/6 mice.
Topics: Animals; Arginine; Collagen; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glomerular Mesangium; Glycation End Products, Advanced; Kidney; Kidney Glomerulus; Lysine; Mice; Mice, Inbred C57BL; Proteinuria; Thiazoles | 2001 |
N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function.
Topics: Adult; Aged; Aged, 80 and over; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Oxidative Stress | 2001 |
Glycoxidation-modified macrophages and lipid peroxidation products are associated with the progression of human diabetic nephropathy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Diabetic Nephropathies; Female; Glycosylation; Humans; Immunohistochemistry; Kidney Glomerulus; Leukocyte Common Antigens; Lipid Peroxidation; Lysine; Macrophages; Male; Middle Aged; Oxidation-Reduction; Phosphatidylcholines; Receptors, Immunologic; Receptors, Scavenger; Scavenger Receptors, Class A; Severity of Illness Index | 2001 |
Daily haemodialysis improves indices of protein glycation.
Topics: Adult; Aged; Arginine; Circadian Rhythm; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Kidney Failure, Chronic; Longitudinal Studies; Lysine; Male; Middle Aged; Molecular Weight; Prospective Studies; Renal Dialysis | 2002 |
Renal function changes in diabetes.
Topics: Antihypertensive Agents; Arginine; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Glomerular Filtration Rate; Glucose; Humans; Insulin; Kidney; Kidney Function Tests; Kidney Glomerulus; Lysine; Male; Organ Size; Proteinuria | 1976 |
Comparison of the chemical composition of glomerular and tubular basement membranes obtained from human kidneys of diabetics and non-diabetics.
Topics: Adult; Aged; Amino Acids; Basement Membrane; Carbohydrates; Cystine; Diabetes Mellitus; Diabetic Nephropathies; Female; Humans; Hydroxylation; Hydroxylysine; Kidney Glomerulus; Kidney Tubules; Lysine; Male; Middle Aged; Phospholipids | 1975 |
Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM.
Topics: Adult; Arginine; Collagen; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Male; Models, Biological; Reference Values; Skin; Skin Aging | 1992 |
Accelerated onset of albuminuria in diabetic rats preimmunized with glucosylated rat serum albumin.
Topics: Albuminuria; Animals; Antibody Formation; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Immunologic; Enzyme-Linked Immunosorbent Assay; Epitopes; Immunization; Lysine; Rats; Serum Albumin; Streptozocin | 1985 |
Studies on amino acid composition of renal glomeruli from the diabetics.
Topics: Aged; Amino Acids; Collagen; Diabetes Mellitus; Diabetic Nephropathies; Female; Humans; Hydroxylysine; Hydroxyproline; Kidney Glomerulus; Lysine; Male; Middle Aged; Proline | 1985 |